ESMO Shares Recommendations to Support Cancer Research and Clinical Trials in Europe By Ogkologos - May 28, 2026 215 0 Facebook Twitter Google+ Pinterest WhatsApp EU Competitiveness Council (Research) Source RELATED ARTICLESMORE FROM AUTHOR Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics with a favourable safety profile Anito-cel, a d-Domain BCMA CAR T-Cell, Induces Rapid, Deep, and Durable Responses in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Relacorilant MOST POPULAR With Longer Follow-Up, Trastuzumab Deruxtecan Continues to Demonstrate Superior Efficacy Over... June 27, 2024 Maintenance Regorafenib Significantly Delays Disease Progression After First-Line Treatment in Patients... April 28, 2025 Niraparib Plus Abiraterone Acetate and Prednisone Improves rPFS and Other Clinically... August 8, 2023 Test Detects Early Signs of Remaining Cancer in Kids Treated for... December 8, 2021 Load more HOT NEWS How Your Oncology Nurse Can Help You During Cancer Withdrawal of Application to Change the Marketing Authorisation for Atezolizumab If You Let It, Nursing Will Change Your Life Neoadjuvant Niraparib Demonstrates Promising Antitumour Activity and Safety in Patients with...
